Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PHENOSAR trial of azithromycin + doxycycline in biopsy-confirmed sarcoidosis phenotypes
NL-OMON56424Recruiting
- Sponsor
- St. Antonius Ziekenhuis
- Start
- Mar 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in sarcoidosis comparing Azithromycin + doxycycline with Placebo (2 arms). Primary endpoint: Difference in inflammatory activation. Started Mar 2023; status: recruiting.
02
Drugs
azithromycindoxycycline
03
Conditions
sarcoidosis
Beyond the preview
Go deeper on NL-OMON56424.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON56424.